A randomized, open-label, controlled study of skincare guidance by health care professionals using cosmetics for patients with skin diseases

Phase 2

Recruiting

• Conditions: Atopic dermatitis, systemic sclerosis, asteatotic eczema, others; D003876, D012595, D004485

• Registration Number: JPRN-jRCT1030220212
• Lead Sponsor: Yoshizaki Ayumi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients who meet all of the following criteria 1)~5)
1) Patients with skin diseases
2) Patients who do not plan to change the drug used to treat the primary disease (no restriction on change in dosage).
3) Be male or female, 20 years of age or older.
4) The subject must be able to practice the skincare instructed at home by him/herself.
5) Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on sufficient understanding.

Exclusion Criteria

1) Persons who have experienced contact dermatitis or other skin conditions caused by the ingredients contained in this skincare product or similar ingredients in the past.
2) Patients who have skin rashes or other skin conditions inappropriate for the application of this skincare product to the area of application.
3) Patients who cannot be examined after 4 to 8 weeks (in principle).
4) Pregnant or nursing mothers
5) Patients with psychiatric disorders or psychiatric symptoms that interfere with daily life and make it difficult for them to participate in the study.
6) Other patients who are deemed inappropriate as research subjects by the investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified